Target Price | $606.71 |
Price | $438.72 |
Potential | 38.29% |
Number of Estimates | 32 |
32 Analysts have issued a price target Intuitive Surgical 2026 . The average Intuitive Surgical target price is $606.71. This is 38.29% higher than the current stock price. The highest price target is $719.25 63.94% , the lowest is $444.40 1.29% . | |
A rating was issued by 40 analysts: 27 Analysts recommend Intuitive Surgical to buy, 12 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Intuitive Surgical stock has an average upside potential 2026 of 38.29% . Most analysts recommend the Intuitive Surgical stock at Purchase. |
37 Analysts have issued a sales forecast Intuitive Surgical 2025 . The average Intuitive Surgical sales estimate is $10.0b . This is 9.16% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $10.5b 14.58% , the lowest is $9.4b 3.18% .
This results in the following potential growth metrics:
2024 | $8.4b | 17.24% |
---|---|---|
2025 | $10.0b | 19.53% |
2026 | $11.4b | 14.49% |
2027 | $13.1b | 15.04% |
2028 | $14.2b | 8.21% |
2029 | $16.7b | 17.32% |
2030 | $19.5b | 16.91% |
2031 | $20.4b | 4.30% |
2032 | $22.6b | 11.14% |
29 Analysts have issued an Intuitive Surgical EBITDA forecast 2025. The average Intuitive Surgical EBITDA estimate is $4.1b . This is 29.02% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.6b 42.21% , the lowest is $3.8b 18.49% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $2.4b | 32.27% |
---|---|---|
2025 | $4.1b | 75.49% |
2026 | $4.7b | 12.92% |
2027 | $5.5b | 18.59% |
2028 | $6.0b | 8.96% |
2029 | $7.4b | 22.84% |
2030 | $9.2b | 24.23% |
2024 | 28.25% | 12.82% |
---|---|---|
2025 | 41.47% | 46.82% |
2026 | 40.90% | 1.37% |
2027 | 42.16% | 3.08% |
2028 | 42.46% | 0.71% |
2029 | 44.46% | 4.71% |
2030 | 47.24% | 6.25% |
38 Intuitive Surgical Analysts have issued a net profit forecast 2025. The average Intuitive Surgical net profit estimate is $3.0b . This is 14.42% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 19.88% , the lowest is $2.8b 7.09% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.3b | 29.18% |
---|---|---|
2025 | $3.0b | 28.46% |
2026 | $3.4b | 13.59% |
2027 | $3.9b | 16.52% |
2028 | $4.4b | 11.50% |
2029 | $5.2b | 17.57% |
2030 | $6.5b | 25.21% |
2024 | 27.81% | 10.18% |
---|---|---|
2025 | 29.89% | 7.48% |
2026 | 29.65% | 0.80% |
2027 | 30.03% | 1.28% |
2028 | 30.95% | 3.06% |
2029 | 31.01% | 0.19% |
2030 | 33.21% | 7.09% |
38 Analysts have issued a Intuitive Surgical forecast for earnings per share. The average Intuitive Surgical EPS is $8.32 . This is 16.04% higher than earnings per share in the financial year 2024. The highest EPS forecast is $8.72 21.62% , the lowest is $7.79 8.65% .
This results in the following potential growth metrics and future valuations:
2024 | $6.42 | 27.63% |
---|---|---|
2025 | $8.32 | 29.60% |
2026 | $9.46 | 13.70% |
2027 | $11.02 | 16.49% |
2028 | $12.28 | 11.43% |
2029 | $14.44 | 17.59% |
2030 | $18.08 | 25.21% |
2031 | $18.07 | 0.06% |
2032 | $19.59 | 8.41% |
Current | 61.19 | 27.68% |
---|---|---|
2025 | 52.70 | 13.87% |
2026 | 46.40 | 11.95% |
2027 | 39.82 | 14.18% |
2028 | 35.71 | 10.32% |
2029 | 30.38 | 14.93% |
2030 | 24.26 | 20.14% |
Based on analysts' sales estimates for 2025, the Intuitive Surgical stock is valued at an EV/Sales of 14.80 and an P/S ratio of 15.75 .
This results in the following potential growth metrics and future valuations:
Current | 16.16 | 27.66% |
---|---|---|
2025 | 14.80 | 8.42% |
2026 | 12.93 | 12.66% |
2027 | 11.24 | 13.07% |
2028 | 10.38 | 7.58% |
2029 | 8.85 | 14.76% |
2030 | 7.57 | 14.47% |
2031 | 7.26 | 4.13% |
2032 | 6.53 | 10.02% |
Current | 17.20 | 25.19% |
---|---|---|
2025 | 15.75 | 8.39% |
2026 | 13.76 | 12.66% |
2027 | 11.96 | 13.07% |
2028 | 11.05 | 7.58% |
2029 | 9.42 | 14.76% |
2030 | 8.06 | 14.47% |
2031 | 7.73 | 4.13% |
2032 | 6.95 | 10.02% |
Intuitive Surgical...
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Aug 19 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Jul 23 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Jul 23 2025 |
BTIG |
Buy
➜
Buy
|
Unchanged | Jul 23 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Jul 23 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 23 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Aug 19 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Jul 23 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Jul 23 2025 |
Unchanged
BTIG:
Buy
➜
Buy
|
Jul 23 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Jul 23 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 23 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.